William Webster Tomford, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Transplantation | 36 | 2012 | 925 | 1.910 |
Why?
|
| Transplantation, Homologous | 26 | 2012 | 4833 | 0.450 |
Why?
|
| Osseointegration | 3 | 2001 | 277 | 0.360 |
Why?
|
| Tissue Banks | 7 | 1995 | 183 | 0.290 |
Why?
|
| Tissue Preservation | 11 | 1999 | 173 | 0.270 |
Why?
|
| Bone Neoplasms | 13 | 2001 | 2565 | 0.250 |
Why?
|
| Orthopedics | 2 | 2012 | 906 | 0.230 |
Why?
|
| Cartilage, Articular | 8 | 1996 | 1104 | 0.210 |
Why?
|
| Freezing | 7 | 1992 | 311 | 0.180 |
Why?
|
| Cartilage | 6 | 1999 | 811 | 0.180 |
Why?
|
| Bone Banks | 1 | 1999 | 4 | 0.170 |
Why?
|
| Tibia | 11 | 2003 | 1076 | 0.170 |
Why?
|
| Antibody Formation | 2 | 2001 | 1393 | 0.160 |
Why?
|
| Polypropylenes | 4 | 2003 | 63 | 0.160 |
Why?
|
| Muscles | 2 | 1995 | 1582 | 0.150 |
Why?
|
| Fumarates | 4 | 2003 | 132 | 0.150 |
Why?
|
| Isoantibodies | 2 | 2001 | 681 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2012 | 3463 | 0.140 |
Why?
|
| Preservation, Biological | 2 | 1987 | 26 | 0.130 |
Why?
|
| Bone Substitutes | 3 | 2003 | 233 | 0.120 |
Why?
|
| Bone Diseases | 2 | 1993 | 416 | 0.120 |
Why?
|
| Osteitis Deformans | 1 | 1994 | 54 | 0.110 |
Why?
|
| Sheep | 3 | 2001 | 1451 | 0.110 |
Why?
|
| Aspergillus flavus | 1 | 1993 | 13 | 0.110 |
Why?
|
| Candida | 1 | 1993 | 173 | 0.100 |
Why?
|
| Femoral Neck Fractures | 1 | 1994 | 143 | 0.100 |
Why?
|
| Joints | 3 | 2001 | 324 | 0.100 |
Why?
|
| Fractures, Spontaneous | 1 | 1994 | 232 | 0.100 |
Why?
|
| Chondrosarcoma | 4 | 2001 | 306 | 0.100 |
Why?
|
| Bone and Bones | 7 | 2002 | 2589 | 0.100 |
Why?
|
| Osteolysis | 1 | 1994 | 274 | 0.100 |
Why?
|
| Femoral Neoplasms | 3 | 2002 | 85 | 0.090 |
Why?
|
| Virus Diseases | 1 | 1995 | 724 | 0.080 |
Why?
|
| Minerals | 2 | 2001 | 282 | 0.080 |
Why?
|
| Osteomyelitis | 1 | 1993 | 408 | 0.080 |
Why?
|
| Bone Demineralization Technique | 3 | 1997 | 27 | 0.080 |
Why?
|
| Temporal Bone | 1 | 1993 | 683 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2012 | 812 | 0.070 |
Why?
|
| Lasers | 2 | 2001 | 952 | 0.070 |
Why?
|
| Osteogenesis | 3 | 1999 | 1288 | 0.070 |
Why?
|
| Postoperative Complications | 9 | 2000 | 15832 | 0.060 |
Why?
|
| Tissue Donors | 4 | 1993 | 2381 | 0.060 |
Why?
|
| Prostheses and Implants | 3 | 2002 | 1276 | 0.060 |
Why?
|
| Osteosarcoma | 4 | 2001 | 911 | 0.060 |
Why?
|
| Femur Head | 1 | 1986 | 297 | 0.060 |
Why?
|
| Specimen Handling | 2 | 1986 | 708 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2003 | 944 | 0.050 |
Why?
|
| Cryoprotective Agents | 1 | 1984 | 128 | 0.050 |
Why?
|
| Graft Survival | 6 | 2002 | 3887 | 0.050 |
Why?
|
| Polymers | 2 | 2000 | 1630 | 0.050 |
Why?
|
| Bone Regeneration | 2 | 2002 | 443 | 0.050 |
Why?
|
| Bacterial Infections | 1 | 1990 | 1397 | 0.050 |
Why?
|
| Radiography | 7 | 2002 | 6983 | 0.050 |
Why?
|
| Surgical Wound Infection | 5 | 2001 | 1546 | 0.050 |
Why?
|
| Polyglycolic Acid | 2 | 2000 | 408 | 0.050 |
Why?
|
| Cross Infection | 1 | 1990 | 1426 | 0.050 |
Why?
|
| Hydrochloric Acid | 2 | 1997 | 76 | 0.040 |
Why?
|
| Fractures, Bone | 4 | 2001 | 2062 | 0.040 |
Why?
|
| Genes, MHC Class I | 1 | 2001 | 235 | 0.040 |
Why?
|
| Animals | 19 | 2012 | 169246 | 0.040 |
Why?
|
| Fractures, Closed | 1 | 2000 | 88 | 0.040 |
Why?
|
| Laser Therapy | 2 | 1997 | 1107 | 0.040 |
Why?
|
| Bone Remodeling | 2 | 2000 | 583 | 0.040 |
Why?
|
| Histocompatibility Testing | 1 | 2001 | 716 | 0.040 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2000 | 160 | 0.040 |
Why?
|
| Lactic Acid | 2 | 2000 | 1140 | 0.040 |
Why?
|
| Follow-Up Studies | 13 | 2002 | 39348 | 0.040 |
Why?
|
| HIV-1 | 2 | 1992 | 6961 | 0.040 |
Why?
|
| Biology | 1 | 1999 | 292 | 0.040 |
Why?
|
| Dimethyl Sulfoxide | 3 | 1996 | 250 | 0.030 |
Why?
|
| Sterilization | 2 | 1991 | 132 | 0.030 |
Why?
|
| Coated Materials, Biocompatible | 1 | 1999 | 311 | 0.030 |
Why?
|
| Absorbable Implants | 1 | 1999 | 337 | 0.030 |
Why?
|
| Tissue and Organ Harvesting | 1 | 1999 | 373 | 0.030 |
Why?
|
| Femoral Fractures | 1 | 2000 | 376 | 0.030 |
Why?
|
| Tissue and Organ Procurement | 2 | 1999 | 986 | 0.030 |
Why?
|
| Bone Matrix | 1 | 1996 | 127 | 0.030 |
Why?
|
| Arthrodesis | 3 | 2002 | 187 | 0.030 |
Why?
|
| Bone Density | 3 | 1997 | 3573 | 0.030 |
Why?
|
| Humans | 39 | 2012 | 768166 | 0.030 |
Why?
|
| Hip Prosthesis | 2 | 1994 | 924 | 0.030 |
Why?
|
| Epiphyses | 1 | 1996 | 191 | 0.030 |
Why?
|
| Cryopreservation | 2 | 1999 | 733 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2002 | 1702 | 0.030 |
Why?
|
| Hepatitis C | 2 | 1995 | 1595 | 0.030 |
Why?
|
| Earache | 1 | 1993 | 14 | 0.030 |
Why?
|
| Early Ambulation | 1 | 1994 | 49 | 0.030 |
Why?
|
| Gamma Rays | 2 | 1992 | 319 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 1996 | 475 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 3814 | 0.030 |
Why?
|
| Amphotericin B | 1 | 1993 | 143 | 0.030 |
Why?
|
| Quality Control | 3 | 1986 | 836 | 0.030 |
Why?
|
| Hearing Disorders | 1 | 1993 | 126 | 0.030 |
Why?
|
| Audiometry | 1 | 1993 | 253 | 0.030 |
Why?
|
| Calcitonin | 1 | 1994 | 328 | 0.030 |
Why?
|
| Tissue Transplantation | 1 | 1993 | 128 | 0.030 |
Why?
|
| Cattle | 3 | 1996 | 3819 | 0.030 |
Why?
|
| Cell Survival | 5 | 1996 | 5777 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 2000 | 928 | 0.020 |
Why?
|
| Corneal Transplantation | 1 | 1995 | 315 | 0.020 |
Why?
|
| Skull | 1 | 1996 | 820 | 0.020 |
Why?
|
| Carcinoma | 1 | 1982 | 2332 | 0.020 |
Why?
|
| Adolescent | 12 | 2002 | 89169 | 0.020 |
Why?
|
| Hip Joint | 2 | 1992 | 1018 | 0.020 |
Why?
|
| Disabled Persons | 1 | 2000 | 1210 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1992 | 876 | 0.020 |
Why?
|
| Disease Transmission, Infectious | 1 | 1995 | 560 | 0.020 |
Why?
|
| Hepatitis B | 1 | 1995 | 711 | 0.020 |
Why?
|
| Male | 22 | 2002 | 364719 | 0.020 |
Why?
|
| Bone Cements | 3 | 2001 | 327 | 0.020 |
Why?
|
| Rats | 6 | 2003 | 23760 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 1995 | 1397 | 0.020 |
Why?
|
| Adult | 18 | 2002 | 223646 | 0.020 |
Why?
|
| Middle Aged | 15 | 2002 | 223492 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2001 | 3556 | 0.020 |
Why?
|
| Immune System | 1 | 1993 | 799 | 0.020 |
Why?
|
| Debridement | 1 | 1990 | 494 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1988 | 235 | 0.020 |
Why?
|
| Child | 8 | 2002 | 80917 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 1971 | 957 | 0.020 |
Why?
|
| Analgesics | 1 | 1994 | 1071 | 0.020 |
Why?
|
| Aged | 11 | 2002 | 171504 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 1995 | 1673 | 0.020 |
Why?
|
| Reoperation | 2 | 2001 | 4329 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2002 | 42669 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 4 | 1999 | 8128 | 0.020 |
Why?
|
| Wound Healing | 3 | 2001 | 2809 | 0.020 |
Why?
|
| Cadaver | 2 | 1988 | 1363 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 1992 | 1312 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2001 | 1791 | 0.020 |
Why?
|
| Organ Transplantation | 1 | 1995 | 1176 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1993 | 1305 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1995 | 3216 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 1991 | 1597 | 0.010 |
Why?
|
| Knee Joint | 1 | 1992 | 1683 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 9263 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1999 | 1441 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1988 | 1627 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 1996 | 11244 | 0.010 |
Why?
|
| Femur | 2 | 2001 | 1321 | 0.010 |
Why?
|
| Orthopedic Fixation Devices | 1 | 1983 | 76 | 0.010 |
Why?
|
| Tissue Survival | 1 | 1983 | 120 | 0.010 |
Why?
|
| Legislation as Topic | 1 | 1983 | 76 | 0.010 |
Why?
|
| Glycerol | 1 | 1984 | 274 | 0.010 |
Why?
|
| Bone Plates | 2 | 2001 | 468 | 0.010 |
Why?
|
| Female | 15 | 2002 | 397192 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1983 | 530 | 0.010 |
Why?
|
| Retrospective Studies | 5 | 2002 | 81762 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 1991 | 2430 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 1999 | 1361 | 0.010 |
Why?
|
| Joint Loose Bodies | 1 | 2001 | 19 | 0.010 |
Why?
|
| Joint Prosthesis | 1 | 1982 | 251 | 0.010 |
Why?
|
| Radiation | 1 | 2000 | 48 | 0.010 |
Why?
|
| Proteoglycans | 1 | 1984 | 809 | 0.010 |
Why?
|
| Internal Fixators | 1 | 2001 | 183 | 0.010 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2001 | 119 | 0.010 |
Why?
|
| Cats | 1 | 1981 | 978 | 0.010 |
Why?
|
| Decalcification Technique | 1 | 1999 | 6 | 0.010 |
Why?
|
| Treatment Outcome | 4 | 2001 | 65371 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 1991 | 9419 | 0.010 |
Why?
|
| Transplantation, Heterologous | 2 | 1999 | 2393 | 0.010 |
Why?
|
| Histocompatibility | 1 | 1999 | 321 | 0.010 |
Why?
|
| Fracture Fixation | 1 | 2001 | 370 | 0.010 |
Why?
|
| Porosity | 1 | 1999 | 352 | 0.010 |
Why?
|
| Tissue Embedding | 1 | 1997 | 43 | 0.010 |
Why?
|
| Transplants | 1 | 2000 | 208 | 0.010 |
Why?
|
| Protective Agents | 1 | 1999 | 150 | 0.010 |
Why?
|
| Diaphyses | 1 | 1997 | 65 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2001 | 20760 | 0.010 |
Why?
|
| Bone Screws | 1 | 2001 | 534 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1988 | 5902 | 0.010 |
Why?
|
| Extremities | 1 | 1982 | 870 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 1988 | 4912 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1996 | 317 | 0.010 |
Why?
|
| Arthroplasty | 1 | 1978 | 308 | 0.010 |
Why?
|
| Surface Properties | 1 | 1999 | 1166 | 0.010 |
Why?
|
| Immunization | 1 | 1999 | 1219 | 0.010 |
Why?
|
| Bone Resorption | 1 | 1999 | 728 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2000 | 59629 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 3436 | 0.010 |
Why?
|
| Diffusion | 1 | 1996 | 815 | 0.010 |
Why?
|
| Risk Factors | 3 | 2000 | 74944 | 0.010 |
Why?
|
| Regeneration | 1 | 1983 | 1524 | 0.010 |
Why?
|
| Arthroscopy | 1 | 2001 | 971 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1996 | 975 | 0.010 |
Why?
|
| United States | 3 | 1995 | 73039 | 0.010 |
Why?
|
| Hepatitis Antibodies | 1 | 1993 | 67 | 0.010 |
Why?
|
| Fibula | 1 | 1995 | 270 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1981 | 2614 | 0.010 |
Why?
|
| Hepatitis C Antibodies | 1 | 1993 | 151 | 0.010 |
Why?
|
| Prognosis | 2 | 1983 | 30010 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1996 | 1340 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1990 | 7477 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1996 | 2120 | 0.010 |
Why?
|
| History, 17th Century | 1 | 1971 | 108 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1996 | 1826 | 0.010 |
Why?
|
| History, Ancient | 1 | 1971 | 213 | 0.010 |
Why?
|
| History, 18th Century | 1 | 1971 | 206 | 0.010 |
Why?
|
| Models, Biological | 2 | 1997 | 9495 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 1996 | 1972 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1983 | 4492 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1996 | 1309 | 0.010 |
Why?
|
| HIV Infections | 1 | 1995 | 17569 | 0.000 |
Why?
|
| Kinetics | 1 | 1996 | 6329 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1996 | 2633 | 0.000 |
Why?
|
| History, 19th Century | 1 | 1971 | 714 | 0.000 |
Why?
|
| Cell Division | 1 | 1996 | 4473 | 0.000 |
Why?
|
| Trypan Blue | 1 | 1988 | 20 | 0.000 |
Why?
|
| Thymidine | 1 | 1988 | 297 | 0.000 |
Why?
|
| Feasibility Studies | 1 | 1999 | 5315 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1996 | 2121 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 12543 | 0.000 |
Why?
|
| Prosthesis Failure | 1 | 1991 | 1208 | 0.000 |
Why?
|
| Hepacivirus | 1 | 1993 | 1344 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1993 | 36743 | 0.000 |
Why?
|
| Survival Rate | 1 | 2000 | 12840 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1996 | 3573 | 0.000 |
Why?
|
| Organ Preservation | 1 | 1988 | 393 | 0.000 |
Why?
|
| Time Factors | 2 | 1988 | 40218 | 0.000 |
Why?
|
| Europe | 1 | 1971 | 3436 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1988 | 2014 | 0.000 |
Why?
|
| Age Factors | 1 | 2001 | 18412 | 0.000 |
Why?
|
| Necrosis | 1 | 1988 | 1616 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1999 | 14783 | 0.000 |
Why?
|
| History, 20th Century | 1 | 1971 | 2766 | 0.000 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1991 | 2204 | 0.000 |
Why?
|
| Incidence | 1 | 2001 | 21538 | 0.000 |
Why?
|
| Hospital Records | 1 | 1981 | 93 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1988 | 1441 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1988 | 2234 | 0.000 |
Why?
|
| Risk | 1 | 1993 | 9613 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1999 | 18349 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1996 | 10266 | 0.000 |
Why?
|
| Methacrylates | 1 | 1978 | 110 | 0.000 |
Why?
|
| Hospitals, General | 1 | 1981 | 809 | 0.000 |
Why?
|
| Cell Line | 1 | 1991 | 15597 | 0.000 |
Why?
|
| Costs and Cost Analysis | 1 | 1981 | 1667 | 0.000 |
Why?
|
| Pregnancy | 1 | 1996 | 30256 | 0.000 |
Why?
|
| Stress, Mechanical | 1 | 1978 | 1676 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1996 | 54926 | 0.000 |
Why?
|
| Boston | 1 | 1981 | 9374 | 0.000 |
Why?
|
| Mice | 1 | 1988 | 82029 | 0.000 |
Why?
|